# Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes

> **NCT05385211** · — · COMPLETED · sponsor: **Ciusss de L'Est de l'Île de Montréal** · enrollment: 100 (actual)

## Conditions studied

- Type 1 Diabetes
- Exocrine Pancreatic Insufficiency

## Interventions

- **OTHER:** Frequency of hypoglycemia in people with type 1 diabetes and exocrine pancreatic insufficiency

## Key facts

- **NCT ID:** NCT05385211
- **Lead sponsor:** Ciusss de L'Est de l'Île de Montréal
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-30
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-08-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-09-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05385211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05385211, "Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05385211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*